Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.290
+0.060 (1.86%)
Feb 13, 2026, 4:08 PM HKT

HKG:1349 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
8,0046,6028,0577,76713,43415,730
Market Cap Growth
26.09%-18.06%3.73%-42.18%-14.60%282.12%
Enterprise Value
6,7995,4656,8506,42712,10614,244
Last Close Price
3.292.442.393.163.423.35
PE Ratio
-156.1367.3249.7951.3180.44
Forward PE
-22.4622.4622.4622.4622.46
PS Ratio
10.298.748.606.669.6015.89
PB Ratio
3.242.693.103.055.006.60
P/TBV Ratio
3.342.783.223.135.206.78
P/FCF Ratio
73.75--88.1373.56187.64
P/OCF Ratio
48.94-102.9841.5740.70117.22
PEG Ratio
-0.690.690.690.690.69
EV/Sales Ratio
8.747.247.315.518.6514.39
EV/EBITDA Ratio
-112.2848.1830.4145.5562.59
EV/EBIT Ratio
--80.5949.8360.6184.03
EV/FCF Ratio
62.65--72.9266.29169.90
Debt / Equity Ratio
0.010.010.010.060.010.01
Debt / EBITDA Ratio
-0.380.130.640.140.10
Debt / FCF Ratio
0.16--1.600.210.28
Net Debt / Equity Ratio
-0.49-0.45-0.50-0.53-0.54-0.69
Net Debt / EBITDA Ratio
21.89-22.64-9.13-6.39-5.44-7.19
Net Debt / FCF Ratio
-11.1017.5042.17-15.32-7.91-19.51
Asset Turnover
0.280.260.290.360.430.41
Inventory Turnover
1.881.401.762.272.261.95
Quick Ratio
8.406.083.602.983.564.63
Current Ratio
8.686.403.703.073.654.74
Return on Equity (ROE)
-2.73%1.69%4.70%6.18%10.12%11.17%
Return on Assets (ROA)
-2.58%-0.18%1.65%2.48%3.85%4.39%
Return on Invested Capital (ROIC)
-8.95%-0.63%6.89%11.02%19.48%23.22%
Return on Capital Employed (ROCE)
-4.60%-0.30%3.30%5.00%7.20%6.90%
Earnings Yield
-0.86%0.64%1.49%2.01%1.95%1.24%
FCF Yield
1.36%-0.95%-0.38%1.14%1.36%0.53%
Dividend Yield
2.10%2.18%3.23%2.50%2.51%1.77%
Payout Ratio
-234.79%70.10%51.48%24.45%42.37%
Buyback Yield / Dilution
24.84%-0.23%-0.29%1.29%-5.59%-7.20%
Total Shareholder Return
26.93%1.95%2.94%3.80%-3.08%-5.42%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.